Amlodipine Besylate (Afcca25d 0e19 4800 A55d 1714067a4400 01)
Amlodipine Besylate Tablet
Product Images NDC 50090-5354
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 50090-5354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
This description includes data points related to a clinical trial comparing the effects of Amlodipine versus a placebo on a group of 1318 patients. The text mentions information about the distribution of patients by gender, baseline sitting SBP levels, baseline vessel disease, vessels with stenosis, PCI-stent strata, and hazard ratio with a 95% confidence interval. The study appears to have subgroup analyses based on different criteria such as gender, vessel conditions, and PCI status.*
Label Image (Lbl500905354)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
